GBM Ab, IgG, Muliplex Bead Assay and IFA




Test Mnemonic

GBMGP

CPT Codes

  • 83516 - QTY (1)
  • 86255 - QTY (1)

Performing Laboratory

ARUP


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
1 mLSerumSST (Gold) RefrigeratedSeparate serum from cells ASAP or within 2 hours of collection

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.3 mL     

Stability

Environmental Condition Description
AmbientAfter separation from cells: 2 days
FrozenAfter separation from cells: 1 year (avoid freeze/thaw cycles)
RefrigeratedAfter separation from cells: 2 weeks

Days Performed

Mon - Fri

Turnaround Time

2 - 6 days

Methodology

Name Description
Indirect Fluorescent Antibody (IFA) 
Multiplex Bead Assay 

Reference Range

GBM Ab, IgG (Bead)
Sex Age From Age To Type Range Range Unit
   Years99 YearsNormalNegative: <=19AU/mL
   Years99 YearsNormalEquivocal: 20 - 25AU/mL
   Years99 YearsNormalPositive: >=26AU/mL

Special Info

Separate serum from cells ASAP or within 2 hours of collection.

Clinical Info

GBM IgG IFA: The anti-GBM IFA methodology has been shown to be less specific than the semi-quantitative tests for circulating antibodies. The antibody used in the Multiplex Bead Assay, although directed to human IgG F (ab')2, can bind to light chain sites common to all immunoglobulins, causing the assay to be more sensitive but less specific. The determination of a positive result is based on a diffuse "linear" staining pattern as viewed through a fluorescent microscope. All positive results should be confirmed by semi-quantitative tests and/or renal biopsy. GBM IgG Muliplex Bead Assay: The presence of anti-glomerular basement membrane (GBM) antibodies by Muliplex Bead assay may aid in the diagnosis of Goodpasture syndrome. False positive results may occur due to reactivity against other chains of type IV collagen. If Multiplex Bead Assay is negative but there is strong suspicion for disease, renal biopsy may be indicated. A renal biopsy may also be essential in suspected Goodpasture disease with renal involvement, allowing diagnostic confirmation and assessment of renal prognosis.